Global analysis of gene expression in the developing brain of Gtf2ird1 knockout mice

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  O'Leary, Jennifer ^a   Osborne, Lucy R ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

SMALL INTERFERING RNA; GTF2IRD1 PROTEIN, MOUSE; MUSCLE PROTEIN; NUCLEAR PROTEIN; RIBOSOME PROTEIN; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIRTH; BRAIN DEVELOPMENT; BRAIN TISSUE; CHROMOSOME 5; CONTROLLED STUDY; DEVELOPMENTAL STAGE; EMBRYO; EMBRYONIC STEM CELL; GENE; GENE EXPRESSION; GENE LOCATION; GENE TARGETING; GENERAL TRANSCRIPTION FACTOR 2 I REPEAT DOMAIN CONTAINING PROTEIN 1 GENE; GENETIC TRANSCRIPTION; GENOTYPE; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; MICROARRAY ANALYSIS; MOUSE; MUTANT; NERVE CELL; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WILD TYPE; 3' UNTRANSLATED REGION; ANIMAL; BRAIN; CELL LINE; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC ASSOCIATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MOUSE MUTANT; REPRODUCIBILITY; SINGLE NUCLEOTIDE POLYMORPHISM;

MUS; RODENTIA;

3' UNTRANSLATED REGIONS; ANIMALS; BRAIN; CELL LINE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE KNOCKDOWN TECHNIQUES; GENETIC ASSOCIATION STUDIES; MICE; MICE, KNOCKOUT; MUSCLE PROTEINS; NEURONS; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBOSOMAL PROTEINS; RNA, SMALL INTERFERING; TRANS-ACTIVATORS;

EID: 80052328281     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023868     Document Type: Article

References (57)

1. Stromme P, Bjornstad PG, Ramstad K, (2002) Prevalence estimation of Williams syndrome. J Child Neurol 17: 269-271.
2. Pober BR, (2010) Williams-Beuren syndrome. N Engl J Med 362: 239-252.
3. Bellugi U, Lichtenberger L, Jones W, Lai Z, St George M, (2000) I. The neurocognitive profile of Williams Syndrome: a complex pattern of strengths and weaknesses. J Cogn Neurosci 12 (Suppl 1): 7-29.
4. Mervis CB, Robinson BF, Bertrand J, Morris CA, Klein-Tasman BP, et al. (2000) The Williams syndrome cognitive profile. Brain Cogn 44: 604-628.
5. Klein-Tasman BP, Mervis CB, (2003) Distinctive personality characteristics of 8-, 9-, and 10-year-olds with Williams syndrome. Dev Neuropsychol 23: 269-290.
6. Leyfer OT, Woodruff-Borden J, Klein-Tasman BP, Fricke JS, Mervis CB, (2006) Prevalence of psychiatric disorders in 4 to 16-year-olds with Williams syndrome. Am J Med Genet B Neuropsychiatr Genet 141B: 615-622.
7. Curran ME, Atkinson DL, Ewart AK, Morris CA, Leppert MF, et al. (1993) The elastin gene is disrupted by a translocation associated with supravalvular aortic stenosis. Cell 73: 159-168.
8. Tassabehji M, Metcalfe K, Donnai D, Hurst J, Reardon W, et al. (1997) Elastin: genomic structure and point mutations in patients with supravalvular aortic stenosis. Hum Mol Genet 6: 1029-1036.
9. Li DY, Toland AE, Boak BB, Atkinson DL, Ensing GJ, et al. (1997) Elastin point mutations cause an obstructive vascular disease, supravalvular aortic stenosis. Hum Mol Genet 6: 1021-1028.
10. Botta A, Novelli G, Mari A, Novelli A, Sabani M, et al. (1999) Detection of an atypical 7q11.23 deletion in Williams syndrome patients which does not include the STX1A and FZD3 genes. J Med Genet 36: 478-480.
11. Heller R, Rauch A, Luttgen S, Schroder B, Winterpacht A, (2003) Partial deletion of the critical 1.5 Mb interval in Williams-Beuren syndrome. J Med Genet 40: e99.
12. Hirota H, Matsuoka R, Chen XN, Salandanan LS, Lincoln A, et al. (2003) Williams syndrome deficits in visual spatial processing linked to GTF2IRD1 and GTF2I on chromosome 7q11.23. Genet Med 5: 311-321.
13. Morris CA, Mervis CB, Hobart HH, Gregg RG, Bertrand J, et al. (2003) GTF2I hemizygosity implicated in mental retardation in Williams syndrome: genotype-phenotype analysis of five families with deletions in the Williams syndrome region. Am J Med Genet A 123A: 45-59.
14. Gagliardi C, Bonaglia MC, Selicorni A, Borgatti R, Giorda R, (2003) Unusual cognitive and behavioural profile in a Williams syndrome patient with atypical 7q11.23 deletion. J Med Genet 40: 526-530.
15. Howald C, Merla G, Digilio MC, Amenta S, Lyle R, et al. (2006) Two high throughput technologies to detect segmental aneuploidies identify new Williams-Beuren syndrome patients with atypical deletions. J Med Genet 43: 266-273.
16. Dai L, Bellugi U, Chen XN, Pulst-Korenberg AM, Jarvinen-Pasley A, et al. (2009) Is it Williams syndrome? GTF2IRD1 implicated in visual-spatial construction and GTF2I in sociability revealed by high resolution arrays. Am J Med Genet A 149A: 302-314.
17. Ferrero GB, Howald C, Micale L, Biamino E, Augello B, et al. (2010) An atypical 7q11.23 deletion in a normal IQ Williams-Beuren syndrome patient. Eur J Hum Genet 18: 33-38.
18. Antonell A, Del Campo M, Magano LF, Kaufmann L, de la Iglesia JM, et al. (2010) Partial 7q11.23 deletions further implicate GTF2I and GTF2IRD1 as the main genes responsible for the Williams-Beuren syndrome neurocognitive profile. J Med Genet 47: 312-320.
19. Young EJ, Lipina T, Tam E, Mandel A, Clapcote SJ, et al. (2008) Reduced fear and aggression and altered serotonin metabolism in Gtf2ird1-targeted mice. Genes Brain Behav 7: 224-234.
20. Proulx E, Young EJ, Osborne LR, Lambe EK, (2010) Enhanced prefrontal serotonin 5-HT(1A) currents in a mouse model of Williams-Beuren syndrome with low innate anxiety. J Neurodev Disord 2: 99-108.
21. Osborne LR, (2011) Genes: The Gene Expression Approach. In: Farran EK, Karmiloff-Smith A, editors. Neuroconstructivism: the multidisiplinary study of atypical development from infancy to adulthood Oxford Oxford University Press.
22. Bayarsaihan D, Bitchevaia N, Enkhmandakh B, Tussie-Luna MI, Leckman JF, et al. (2003) Expression of BEN, a member of TFII-I family of transcription factors, during mouse pre- and postimplantation development. Gene Expr Patterns 3: 579-589.
23. Palmer SJ, Tay ES, Santucci N, Cuc Bach TT, Hook J, et al. (2007) Expression of Gtf2ird1, the Williams syndrome-associated gene, during mouse development. Gene Expr Patterns 7: 396-404.
24. Jackson TA, Taylor HE, Sharma D, Desiderio S, Danoff SK, (2005) Vascular endothelial growth factor receptor-2: counter-regulation by the transcription factors, TFII-I and TFII-IRD1. J Biol Chem 280: 29856-29863.
25. Issa LL, Palmer SJ, Guven KL, Santucci N, Hodgson VR, et al. (2006) MusTRD can regulate postnatal fiber-specific expression. Dev Biol 293: 104-115.
26. Thompson PD, Webb M, Beckett W, Hinsley T, Jowitt T, et al. (2007) GTF2IRD1 regulates transcription by binding an evolutionarily conserved DNA motif 'GUCE'. FEBS Lett 581: 1233-1242.
27. Bayarsaihan D, Ruddle FH, (2000) Isolation and characterization of BEN, a member of the TFII-I family of DNA-binding proteins containing distinct helix-loop-helix domains. Proc Natl Acad Sci U S A 97: 7342-7347.
28. Ring C, Ogata S, Meek L, Song J, Ohta T, et al. (2002) The role of a Williams-Beuren syndrome-associated helix-loop-helix domain-containing transcription factor in activin/nodal signaling. Genes Dev 16: 820-835.
29. Ku M, Sokol SY, Wu J, Tussie-Luna MI, Roy AL, et al. (2005) Positive and negative regulation of the transforming growth factor beta/activin target gene goosecoid by the TFII-I family of transcription factors. Mol Cell Biol 25: 7144-7157.
30. Chimge NO, Makeyev AV, Ruddle FH, Bayarsaihan D, (2008) Identification of the TFII-I family target genes in the vertebrate genome. Proc Natl Acad Sci U S A 105: 9006-9010.
31. Chimge NO, Mungunsukh O, Ruddle F, Bayarsaihan D, (2007) Expression profiling of BEN regulated genes in mouse embryonic fibroblasts. J Exp Zool B Mol Dev Evol 308: 209-224.
32. Vullhorst D, Buonanno A, (2005) Multiple GTF2I-like repeats of general transcription factor 3 exhibit DNA binding properties. Evidence for a common origin as a sequence-specific DNA interaction module. J Biol Chem 280: 31722-31731.
33. Lazebnik MB, Tussie-Luna MI, Roy AL, (2008) Determination and functional analysis of the consensus binding site for TFII-I family member BEN, implicated in Williams-Beuren syndrome. J Biol Chem 283: 11078-11082.
34. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264.
35. Tusher VG, Tibshirani R, Chu G, (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98: 5116-5121.
36. Smyth GK, (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3: Article3.
37. Bolstad BM, Irizarry RA, Astrand M, Speed TP, (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19: 185-193.
38. Enkhmandakh B, Makeyev AV, Erdenechimeg L, Ruddle FH, Chimge NO, et al. (2009) Essential functions of the Williams-Beuren syndrome-associated TFII-I genes in embryonic development. Proc Natl Acad Sci U S A 106: 181-186.
39. Tassabehji M, Hammond P, Karmiloff-Smith A, Thompson P, Thorgeirsson SS, et al. (2005) GTF2IRD1 in craniofacial development of humans and mice. Science 310: 1184-1187.
40. Palmer SJ, Santucci N, Widagdo J, Bontempo SJ, Taylor KM, et al. (2010) Negative autoregulation of GTF2IRD1 in Williams-Beuren syndrome via a novel DNA binding mechanism. J Biol Chem 285: 4715-4724.
41. Osborne LR, (2010) Animal models of Williams syndrome. Am J Med Genet C Semin Med Genet 154C: 209-219.
42. Wu JI, Lessard J, Olave IA, Qiu Z, Ghosh A, et al. (2007) Regulation of dendritic development by neuron-specific chromatin remodeling complexes. Neuron 56: 94-108.
43. Darios F, Davletov B, (2006) Omega-3 and omega-6 fatty acids stimulate cell membrane expansion by acting on syntaxin 3. Nature 440: 813-817.
44. Rodger J, Davis S, Laroche S, Mallet J, Hicks A, (1998) Induction of long-term potentiation in vivo regulates alternate splicing to alter syntaxin 3 isoform expression in rat dentate gyrus. J Neurochem 71: 666-675.
45. Valor LM, Grant SG, (2007) Clustered gene expression changes flank targeted gene loci in knockout mice. PLoS One 2: e1303.
46. Kedmi M, Orr-Urtreger A, (2007) Differential brain transcriptome of beta4 nAChR subunit-deficient mice: is it the effect of the null mutation or the background strain? Physiol Genomics 28: 213-222.
47. Schalkwyk LC, Fernandes C, Nash MW, Kurrikoff K, Vasar E, et al. (2007) Interpretation of knockout experiments: the congenic footprint. Genes Brain Behav 6: 299-303.
48. Noyes HA, Agaba M, Anderson S, Archibald AL, Brass A, et al. (2010) Genotype and expression analysis of two inbred mouse strains and two derived congenic strains suggest that most gene expression is trans regulated and sensitive to genetic background. BMC Genomics 11: 361.
49. Tudor M, Akbarian S, Chen RZ, Jaenisch R, (2002) Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain. Proc Natl Acad Sci U S A 99: 15536-15541.
50. Caraveo G, van Rossum DB, Patterson RL, Snyder SH, Desiderio S, (2006) Action of TFII-I outside the nucleus as an inhibitor of agonist-induced calcium entry. Science 314: 122-125.
51. Li Y, Jia YC, Cui K, Li N, Zheng ZY, et al. (2005) Essential role of TRPC channels in the guidance of nerve growth cones by brain-derived neurotrophic factor. Nature 434: 894-898.
52. Tai C, Hines DJ, Choi HB, Macvicar BA, (2010) Plasma membrane insertion of TRPC5 channels contributes to the cholinergic plateau potential in hippocampal CA1 pyramidal neurons. Hippocampus doi:10.1002/hipo.20807.
53. Riccio A, Li Y, Moon J, Kim KS, Smith KS, et al. (2009) Essential role for TRPC5 in amygdala function and fear-related behavior. Cell 137: 761-772.
54. Vullhorst D, Buonanno A, (2003) Characterization of general transcription factor 3, a transcription factor involved in slow muscle-specific gene expression. J Biol Chem 278: 8370-8379.
55. Tussie-Luna MI, Bayarsaihan D, Ruddle FH, Roy AL, (2001) Repression of TFII-I-dependent transcription by nuclear exclusion. Proc Natl Acad Sci U S A 98: 7789-7794.
56. O'Mahoney JV, Guven KL, Lin J, Joya JE, Robinson CS, et al. (1998) Identification of a novel slow-muscle-fiber enhancer binding protein, MusTRD1. Mol Cell Biol 18: 6641-6652.
57. Calvo S, Vullhorst D, Venepally P, Cheng J, Karavanova I, et al. (2001) Molecular dissection of DNA sequences and factors involved in slow muscle-specific transcription. Mol Cell Biol 21: 8490-8503.